Inventor
David Austin MORENO
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07CAcyclic or carbocyclic compounds12%
PatentTitleYear
12,303,509Compounds for the treatment of BRAF-associated diseases and disorders202511,802,1273,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors202311,691,9733,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors202311,634,409Compounds for the treatment of BRAF-associated diseases and disorders202311,414,404Compounds for the treatment of BRAF-associated diseases and disorders2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to ARRAY BIOPHARMA INC (2)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to PFIZER (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PFIZER | 3 | 2023–2025 |
| ARRAY BIOPHARMA INC | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |